72.71
Schlusskurs vom Vortag:
$73.82
Offen:
$73.44
24-Stunden-Volumen:
504.26K
Relative Volume:
0.70
Marktkapitalisierung:
$3.65B
Einnahmen:
$379.25M
Nettoeinkommen (Verlust:
$-77.34M
KGV:
-45.10
EPS:
-1.6122
Netto-Cashflow:
$-27.87M
1W Leistung:
-0.33%
1M Leistung:
-2.90%
6M Leistung:
+85.86%
1J Leistung:
+88.96%
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
Firmenname
Mirum Pharmaceuticals Inc
Sektor
Branche
Telefon
650-667-4085
Adresse
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Vergleichen Sie MIRM mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MIRM
Mirum Pharmaceuticals Inc
|
72.71 | 3.71B | 379.25M | -77.34M | -27.87M | -1.6122 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-09-24 | Eingeleitet | TD Cowen | Buy |
2025-08-11 | Fortgesetzt | Stifel | Buy |
2025-05-19 | Fortgesetzt | H.C. Wainwright | Buy |
2024-04-17 | Eingeleitet | Stifel | Buy |
2023-12-18 | Bestätigt | H.C. Wainwright | Buy |
2023-11-20 | Fortgesetzt | JP Morgan | Overweight |
2023-11-13 | Eingeleitet | Morgan Stanley | Overweight |
2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
2023-10-17 | Fortgesetzt | Evercore ISI | Outperform |
2023-09-20 | Eingeleitet | JMP Securities | Mkt Outperform |
2022-09-01 | Eingeleitet | Citigroup | Buy |
2021-09-20 | Eingeleitet | JP Morgan | Overweight |
2020-08-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
2020-08-03 | Eingeleitet | H.C. Wainwright | Buy |
2020-07-31 | Eingeleitet | Piper Sandler | Overweight |
2020-06-25 | Eingeleitet | Robert W. Baird | Outperform |
2019-08-12 | Eingeleitet | Citigroup | Buy |
2019-08-12 | Eingeleitet | Evercore ISI | Outperform |
2019-08-12 | Eingeleitet | Guggenheim | Buy |
2019-08-12 | Eingeleitet | ROTH Capital | Buy |
2019-08-12 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Mirum Pharmaceuticals Inc Aktie (MIRM) Neueste Nachrichten
Technical signs of recovery in Mirum Pharmaceuticals Inc.Oil Prices & Short-Term High Return Ideas - newser.com
Is Mirum Pharmaceuticals Inc. reversing from oversold territory2025 Technical Patterns & Low Drawdown Investment Ideas - newser.com
Mirum Pharmaceuticals' (MIRM) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
How to use a screener to detect Mirum Pharmaceuticals Inc. breakoutsJuly 2025 Volume & High Accuracy Swing Entry Alerts - newser.com
Can Mirum Pharmaceuticals Inc. (08D) stock survive global slowdownInflation Watch & Low Drawdown Investment Ideas - newser.com
Is Mirum Pharmaceuticals Inc 08D a good long term investmentRisk Management Strategies & Affordable Portfolio Trading - earlytimes.in
Will Mirum Pharmaceuticals Inc. rebound enough to break evenDollar Strength & Daily Profit Focused Screening - newser.com
Branded Website for Consumers 2025 - Medical Marketing and Media
Mirum Pharmaceuticals stock hits all-time high at 78.23 USD - Investing.com India
What data driven models say about Mirum Pharmaceuticals Inc.’s futureJuly 2025 Opening Moves & Real-Time Market Sentiment Alerts - newser.com
Will Mirum Pharmaceuticals Inc. stock recover faster than peersIndex Update & Risk Controlled Daily Trade Plans - newser.com
Custom watchlist performance reports with Mirum Pharmaceuticals Inc.2025 Trading Recap & Stock Portfolio Risk Control - newser.com
Is Mirum Pharmaceuticals Inc. stock near bottom after declineDollar Strength & Free Real-Time Market Sentiment Alerts - newser.com
How to integrate Mirum Pharmaceuticals Inc. into portfolio analysis toolsEarnings Growth Summary & Fast Exit/Entry Strategy Plans - newser.com
Why Mirum Pharmaceuticals Inc. (08D) stock is listed among top recommendationsQuarterly Market Summary & Technical Pattern Recognition Alerts - newser.com
How sentiment analysis helps forecast Mirum Pharmaceuticals Inc.Sell Signal & AI Enhanced Trading Signals - newser.com
Identifying reversal signals in Mirum Pharmaceuticals Inc.July 2025 Technicals & Daily Entry Point Alerts - newser.com
Mirum Pharmaceuticals, Inc. $MIRM Shares Sold by Wealth Enhancement Advisory Services LLC - MarketBeat
Is Mirum Pharmaceuticals Inc. forming a bottoming baseQuarterly Performance Summary & Risk Controlled Stock Pick Alerts - newser.com
Price action breakdown for Mirum Pharmaceuticals Inc.Market Activity Report & Stepwise Entry and Exit Trade Signals - newser.com
Is Mirum Pharmaceuticals Inc a good long term investmentBearish Engulfing Patterns & Free Wealth Planning Blueprints - earlytimes.in
Mirum Pharmaceuticals stock soars to all-time high of $49.59 - MSN
Mirum draws new Buy at TD Cowen on growth prospects - MSN
Finanzdaten der Mirum Pharmaceuticals Inc-Aktie (MIRM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Mirum Pharmaceuticals Inc-Aktie (MIRM) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Brege Laura | Director |
Sep 11 '25 |
Sale |
74.40 |
17,000 |
1,264,868 |
15,703 |
BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER |
Sep 12 '25 |
Sale |
76.01 |
9,578 |
728,024 |
39,945 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):